Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00386282
Status:
COMPLETED
Last Update Posted:
2014-07-30
First Post:
2006-10-09
Brief Title:
Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol
Sponsor:
Gynuity Health Projects
Organization:
Gynuity Health Projects
Study Overview
Official Title:
Acceptability and Feasibility of Medical Abortion in Mexico Puerto Rico Armenia and Azerbaijan A Study of Buccal Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation
Status:
COMPLETED
Status Verified Date:
2014-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study examined the acceptability and feasibility of introducing a mifepristone-misoprostol regimen of medical abortion into abortion services in two private clinics in Puerto Rico 2 clinics in Baku Azerbaijan 3 clinics in Yerevan Armenia and 4 clinics in Mexico City It was hypothesized that the study regimen would be both acceptable and efficacious
Detailed Description:
The study recruited women with pregnancies up to 63 days gestation Eligible women took 200 mg mifepristone followed by 800 buccal misoprostol They later underwent clinic follow-up to determine if their medical abortions were complete The study assessed the acceptability and feasibility of the above regimen and sought to determine the efficacy and acceptability of buccal administration of misoprostol as well as the acceptability of side effects experienced by women
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None